Traditional Chinese Medicine Integrated with Chemotherapy for Stage II-IIIA Patients with Non-Small-Cell Lung Cancer after Radical Surgery: A Retrospective Clinical Analysis with Small Sample Size

机译：中药与化学疗法联合治疗非小细胞肺癌II-IIIA期根治术后患者：小样本回顾性临床分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective This study was designed to evaluate the clinical efficacy of combined traditional Chinese medicine (TCM) and conventional chemotherapy versus conventional chemotherapy in patients with stage II-IIIA non-small-cell lung cancer (NSCLC) after radical surgery.

机译：目的本研究旨在评估中药（TCM）和传统化学疗法与传统化学疗法相比较传统疗法与常规化学疗法在II-IIIA期非小细胞肺癌（NSCLC）术后患者中的临床疗效。

著录项

期刊名称 Evidence-based Complementary and Alternative Medicine : eCAM
作者
Xueyu Zhao; Xiaojun Dai; Shanshan Wang; Ting Yang; Yan Yan; Guang Zhu; Jun Feng; Bo Pan; Masataka Sunagawa; Xiaochun Zhang; Yayun Qian; Yanqing Liu;
展开▼
作者单位

展开▼
年(卷),期 2018(2018),-1
年度 2018
页码 4369027
总页数 7
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Traditional Chinese Medicine Integrated with Chemotherapy for Stage II-IIIA Patients with Non-Small-Cell Lung Cancer after Radical Surgery: A Retrospective Clinical Analysis with Small Sample Size [J] . Xueyu Zhao, Xiaojun Dai, Shanshan Wang, Evidence-based complementary and alternative medicine: eCAM . 2018,第3期

机译：中医结合化学疗法治疗II-IIIA期非小细胞肺癌根治术后患者：小样本回顾性临床分析
2. Traditional Chinese Medicine Integrated with Chemotherapy for Stage II-IIIA Patients with Non-Small-Cell Lung Cancer after Radical Surgery: A Retrospective Clinical Analysis with Small Sample Size [J] . Xueyu Zhao, Xiaojun Dai, Shanshan Wang, Evidence-based complementary and alternative medicine: eCAM . 2018,第3期

机译：中医结合化学疗法治疗II-IIIA期非小细胞肺癌根治术后患者：小样本回顾性临床分析
3. Traditional Chinese Medicine Integrated with Chemotherapy for Stage II-IIIA Patients with Non-Small-Cell Lung Cancer after Radical Surgery: A Retrospective Clinical Analysis with Small Sample Size [J] . Zhao Xueyu, Dai Xiaojun, Wang Shanshan, Evidence-based complementary and alternative medicine: eCAM . 2018,第8期

机译：中药与阶段II-IIIA患者的化疗，自由基手术后II-IIIA患者：具有小样本尺寸的回顾性临床分析
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. Astragalus-containing Traditional Chinese Medicine with and without prescription based on syndrome differentiation combined with chemotherapy for advanced non-small-cell lung cancer: a systemic review and meta-analysis [O] . S.F. Wang, Q. Wang, L.J. Jiao, 2016

机译：含黄芪的中药有或没有基于辨证论治的处方联合化疗治疗晚期非小细胞肺癌：系统评价和荟萃分析
7. Feasibility and Efficacy of Adjuvant Chemotherapy with a Split-dose Regimen of Cisplatin Plus Vinorelbine in Japanese Patients with Completely Resected Stage II-IIIA Non-small Cell Lung Cancer -A Retrospective Analysis- [O] . Teppei Yamaguchi, Toru Nakanishi, Sumito Isogai, 2013

机译：佐剂化疗与日本患者分解患者分解阶段IIIIA非小细胞肺癌的日本患者分裂化疗的可行性和疗效与副血管血列患者 - 回顾性分析 -

Traditional Chinese Medicine Integrated with Chemotherapy for Stage II-IIIA Patients with Non-Small-Cell Lung Cancer after Radical Surgery: A Retrospective Clinical Analysis with Small Sample Size

摘要

著录项

相似文献

相关主题

期刊订阅